US$ 28.97
blindness glp 1 GLP-1 Agonists—commonly used for weight loss and diabetes—are now being linked to serious eye health concerns, including an increased risk of a condition called NAION, which can cause irreversible blindness. With GLP-1 glp 1 drugs blindness Exploring
Description
Girges C, Vijiaratnam N, Athauda D, Auld G, Gandhi S, Foltynie T
received research support from Novo Nordisk, Eli Lilly and Company, Boehringer, and Dexcom and consulting/advisory/honoraria fees from Abbott Diabetes, AstraZeneca, Bayer, Boehringer, Dexcom, Eli Lilly and Company, Novo Nordisk, and Medtronic

Category: GLP-1

Yao said

It is important to note that Hers does not accept insurance and instead operates on a subscription model
DeYoung MB, MacConell L, Sarin V, et al